The benefits of
testing your patients
When you suspect that a patient may have AD or PD, Duritect™ streamlines the diagnostic process by providing information to help you make quicker, more informed decisions.
Enable better risk assessment
Categorizing your patients by risk level helps you refer or monitor patients for conditions mimicking early AD or PD – avoiding unnecessary diagnostic tests.1-3
Reduce uncertainties
The highly accurate AD and PD risk scores could help reduce uncertainty and accelerate the process of differential diagnosis –improving the efficiency of diagnostic resources.1-3
Facilitate earlier intervention
A faster process could enable earlier intervention and treatment for your patients, ensuring timely and appropriate care – which could lead to better outcomes.3,4
.png)
Join the Early
Adopters Program
Are you passionate about advancing the diagnosis and treatment of neurodegenerative diseases? Do you thrive on innovation and the opportunity to shape the future of healthcare?
If you’re involved in diagnosing and treating neurodegenerative diseases, we invite you to become an early adopter of Duritect™.